| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 102.86B | 99.45B | 105.88B | 92.11B | 89.12B | 92.65B |
| Gross Profit | 18.00B | 18.59B | 18.38B | 16.13B | 13.99B | 14.62B |
| EBITDA | 9.53B | 10.84B | 9.92B | 9.34B | 8.12B | 8.00B |
| Net Income | 5.01B | 7.50B | 5.17B | 4.57B | 3.76B | 3.78B |
Balance Sheet | ||||||
| Total Assets | 90.58B | 103.87B | 99.63B | 103.20B | 97.07B | 96.52B |
| Cash, Cash Equivalents and Short-Term Investments | 15.59B | 18.27B | 16.96B | 23.06B | 20.60B | 20.12B |
| Total Debt | 6.16B | 7.89B | 8.46B | 10.05B | 11.48B | 13.01B |
| Total Liabilities | 26.22B | 32.67B | 34.74B | 41.41B | 41.16B | 42.34B |
| Stockholders Equity | 64.27B | 71.09B | 64.81B | 61.74B | 55.85B | 54.12B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.02B | -2.02B | 4.62B | 2.45B | 8.51B |
| Operating Cash Flow | 0.00 | 4.01B | -536.00M | 6.04B | 3.81B | 9.92B |
| Investing Cash Flow | 0.00 | 947.00M | -1.18B | -598.00M | 148.00M | -1.59B |
| Financing Cash Flow | 0.00 | -3.69B | -4.28B | -3.11B | -3.13B | -2.55B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥262.06B | 13.33 | 7.43% | 2.78% | 2.69% | -6.90% | |
78 Outperform | ¥1.40T | 18.80 | 14.94% | 2.00% | 10.44% | 50.36% | |
78 Outperform | ¥685.36B | 16.51 | ― | 2.15% | 0.46% | 38.67% | |
77 Outperform | ¥97.86B | 11.64 | ― | 4.38% | -6.07% | 44.83% | |
70 Outperform | ¥570.41B | 14.38 | ― | 2.51% | 15.78% | 72.49% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |